Goodwill of Anika Therapeutics, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Anika Therapeutics, Inc. quarterly Goodwill in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Anika Therapeutics, Inc. Goodwill for the quarter ending 30 Sep 2025 was $8,051,000, a 5.2% increase year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Anika Therapeutics, Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $8,051,000 +$395,000 +5.2% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $8,056,000 +$706,000 +9.6% 30 Jun 2025 10-Q 30 Jul 2025 2025 Q2
Q1 2025 $7,423,000 +$20,000 +0.27% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $7,125,000 -$446,000 -5.9% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $7,656,000 +$403,000 +5.6% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $7,350,000 -$117,000 -1.6% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $7,403,000 -$59,000 -0.79% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $7,571,000 +$232,000 +3.2% 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q3 2023 $7,253,000 +$532,000 +7.9% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $7,467,000 +$298,000 +4.2% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $7,462,000 -$163,000 -2.1% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $7,339,000 -$442,000 -5.7% 31 Dec 2022 10-K 17 Mar 2025 2024 FY
Q3 2022 $6,721,000 -$1,229,000 -15% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $7,169,000 -$980,000 -12% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $7,625,000 -$420,000 -5.2% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $7,781,000 -$632,000 -7.5% 31 Dec 2021 10-K 15 Mar 2024 2023 FY
Q3 2021 $7,950,000 -$24,469,000 -75% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $8,149,000 -$25,809,000 -76% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $8,045,000 -$25,757,000 -76% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $8,413,000 +$719,000 +9.3% 31 Dec 2020 10-K 16 Mar 2023 2022 FY
Q3 2020 $32,419,000 +$24,930,000 +333% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $33,958,000 +$26,160,000 +335% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $33,802,000 +$26,108,000 +339% 31 Mar 2020 10-Q 22 May 2020 2020 Q1
Q4 2019 $7,694,000 -$157,000 -2% 31 Dec 2019 10-K 11 Mar 2022 2021 FY
Q3 2019 $7,489,000 -$470,000 -5.9% 30 Sep 2019 10-Q 28 Oct 2019 2019 Q3
Q2 2019 $7,798,000 -$215,000 -2.7% 30 Jun 2019 10-Q 26 Jul 2019 2019 Q2
Q1 2019 $7,694,000 -$758,000 -9% 31 Mar 2019 10-Q 22 May 2020 2020 Q1
Q4 2018 $7,851,000 -$367,000 -4.5% 31 Dec 2018 10-K/A 26 Apr 2021 2020 FY
Q3 2018 $7,959,000 -$145,000 -1.8% 30 Sep 2018 10-Q 26 Oct 2018 2018 Q3
Q2 2018 $8,013,000 +$177,000 +2.3% 30 Jun 2018 10-Q 31 Jul 2018 2018 Q2
Q1 2018 $8,452,000 +$1,124,000 +15% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $8,218,000 +$1,004,000 +14% 31 Dec 2017 10-K 06 Mar 2020 2019 FY
Q3 2017 $8,104,000 +$414,000 +5.4% 30 Sep 2017 10-Q 27 Oct 2017 2017 Q3
Q2 2017 $7,836,000 +$268,000 +3.5% 30 Jun 2017 10-Q 28 Jul 2017 2017 Q2
Q1 2017 $7,328,000 -$462,000 -5.9% 31 Mar 2017 10-Q 04 May 2017 2017 Q1
Q4 2016 $7,214,000 -$268,000 -3.6% 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q3 2016 $7,690,000 -$23,039 -0.3% 30 Sep 2016 10-Q 01 Nov 2016 2016 Q3
Q2 2016 $7,568,000 -$42,821 -0.56% 30 Jun 2016 10-Q 01 Aug 2016 2016 Q2
Q1 2016 $7,790,000 +$346,571 +4.7% 31 Mar 2016 10-Q 03 May 2016 2016 Q1
Q4 2015 $7,482,000 -$857,000 -10% 31 Dec 2015 10-K 27 Feb 2018 2017 FY
Q3 2015 $7,713,039 -$989,256 -11% 30 Sep 2015 10-Q 03 Nov 2015 2015 Q3
Q2 2015 $7,610,821 -$1,750,063 -19% 30 Jun 2015 10-Q 04 Aug 2015 2015 Q2
Q1 2015 $7,443,429 -$1,990,860 -21% 31 Mar 2015 10-Q 04 May 2015 2015 Q1
Q4 2014 $8,339,000 -$1,105,000 -12% 31 Dec 2014 10-K 24 Feb 2017 2016 FY
Q3 2014 $8,702,295 -$572,835 -6.2% 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 $9,360,884 +$437,687 +4.9% 30 Jun 2014 10-Q 06 Nov 2014 2014 Q3
Q1 2014 $9,434,289 +$642,124 +7.3% 31 Mar 2014 10-Q 04 Aug 2014 2014 Q2
Q4 2013 $9,444,000 +$378,109 +4.2% 31 Dec 2013 10-K 10 Mar 2016 2015 FY
Q3 2013 $9,275,130 $0 0% 30 Sep 2013 10-Q 05 Nov 2013 2013 Q3
Q2 2013 $8,923,197 +$295,679 +3.4% 30 Jun 2013 10-Q 05 Nov 2013 2013 Q3
Q1 2013 $8,792,165 -$358,108 -3.9% 31 Mar 2013 10-Q 06 Aug 2013 2013 Q2
Q4 2012 $9,065,891 $0 0% 31 Dec 2012 10-K 13 Mar 2015 2014 FY
Q3 2012 $9,275,130 -$52,825 -0.57% 30 Sep 2012 10-Q 05 Nov 2013 2013 Q3
Q2 2012 $8,627,518 -$1,244,459 -13% 30 Jun 2012 10-Q 08 Nov 2012 2012 Q3
Q1 2012 $9,150,273 31 Mar 2012 10-Q 07 Aug 2012 2012 Q2
Q4 2011 $9,065,891 -$26,069 -0.29% 31 Dec 2011 10-Q 05 Nov 2013 2013 Q3
Q3 2011 $9,327,955 30 Sep 2011 10-Q 04 Nov 2011 2011 Q3
Q2 2011 $9,871,977 30 Jun 2011 10-Q/A 10 Aug 2011 2011 Q2
Q4 2010 $9,091,960 31 Dec 2010 10-K 13 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.